PV
Patri Venkat Raghavendra Rao
About Patri Venkat Raghavendra Rao
Data last updated:
Patri Venkat Raghavendra Rao was a Cfo at Solara Active Pharma Sciences Limited (2023–2024), Director at Sequent Research Limited (2022–2023) and Cfo at Alivira Animal Health Limited (2022–2023), and held 1 more directorship. The companies operate in Pharma and Chemicals.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 26 Oct 2023 | 2017 | ₹1,292 Cr (FY 2025) | Active | |
| Director | 07 Nov 2022 | 2007 | ₹9.52 Cr (FY 2025) | Amalgamated | |
| Cfo | 08 Aug 2022 | 2013 | ₹393 Cr (FY 2025) | Active | |
| Cfo | 25 Jul 2022 | 1985 | ₹3,464 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Patri Venkat Raghavendra Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Patri Venkat Raghavendra Rao
Patri Venkat Raghavendra Rao was first appointed on 25 Jul 2022 as Cfo at Sequent Scientific Limited. The most recent appointment on record is 26 Oct 2023 at Solara Active Pharma Sciences Limited.
Patri Venkat Raghavendra Rao held 4 earlier board appointments: Solara Active Pharma Sciences Limited (Cfo, 26 Oct 2023 to 15 Feb 2024); Sequent Research Limited (Director, 07 Nov 2022 to 16 Oct 2023); Alivira Animal Health Limited (Cfo, 08 Aug 2022 to 25 Oct 2023); Sequent Scientific Limited (Cfo, 25 Jul 2022 to 25 Oct 2023).